Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide, a synthetic nine-amino acid tag (YPYDVPDYA), is an established molecular tool for precise detection and purification of HA-tagged fusion proteins in research workflows (APExBIO). It competitively binds anti-HA antibodies to enable efficient elution in immunoprecipitation assays, with solubility exceeding 55 mg/mL in DMSO and >98% purity confirmed by HPLC and mass spectrometry. The HA tag is validated in protein-protein interaction studies, ubiquitin pathway analysis, and quantitative immunoassays (Dong et al., 2025). Proper storage at -20°C and use of fresh solutions are critical for optimal stability and activity. This resource builds on benchmarking and best practices from prior HA tag literature, providing atomic, machine-readable guidance for advanced applications.

Biological Rationale

The Influenza Hemagglutinin (HA) Peptide is derived from the human influenza virus hemagglutinin protein, specifically from its immunodominant epitope recognized by monoclonal antibodies (see prior review). Its nine-amino acid sequence (YPYDVPDYA) provides a compact, non-immunogenic tag for exogenous fusion to proteins of interest. The HA tag enables researchers to track, purify, and quantify tagged proteins in cellular and biochemical assays. Its use is especially prevalent in studies requiring highly specific and reversible antibody-based detection, such as in immunoprecipitation, immunoblotting, and immunofluorescence. Unlike endogenous protein epitopes, the HA tag sequence is rare in eukaryotic proteomes, minimizing off-target antibody interactions (expanded in detection specificity context). The HA tag's widespread adoption is attributed to its chemical stability, sequence simplicity, and compatibility with a vast array of anti-HA antibodies and conjugates.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide functions as an epitope tag by mimicking the native antigenic determinant recognized by anti-HA monoclonal antibodies. In protein tagging applications, the HA tag is genetically fused to the N- or C-terminus of a target protein via recombinant DNA techniques. Upon expression, the HA-tagged protein can be selectively captured using immobilized anti-HA antibodies, such as in immunoprecipitation (IP) or immunoaffinity chromatography. During elution, synthetic HA peptide (e.g., APExBIO A6004) is added in molar excess to compete with the tagged protein for antibody binding sites, displacing the fusion protein under gentle, non-denaturing conditions (product protocol). This competitive binding preserves protein conformation and protein-protein interactions, critical for downstream analyses such as mass spectrometry, enzyme assays, and structural studies. The HA peptide is highly soluble in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL), ensuring compatibility with diverse buffer systems and experimental designs.

Evidence & Benchmarks

• HA-tagged fusion proteins can be efficiently eluted from anti-HA antibody matrices using synthetic HA peptide at concentrations as low as 0.2–1 mg/mL, preserving protein complex integrity (Dong et al., 2025, https://doi.org/10.1002/advs.202504704).
• The APExBIO Influenza Hemagglutinin (HA) Peptide (SKU A6004) achieves >98% purity, validated by high-performance liquid chromatography and mass spectrometry (manufacturer data, product page).
• HA peptide enables quantitative, reproducible elution of HA-tagged proteins in immunoprecipitation workflows, supporting downstream mass spectrometry and Western blotting (AP24534 2022).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water at ambient temperature (product specification, APExBIO).
• Storage at -20°C in desiccated form and avoidance of prolonged solution storage maintain peptide stability for 12+ months (real-world workflow report).

Applications, Limits & Misconceptions

The HA peptide is a versatile reagent in molecular biology, biochemistry, and cell biology. Its primary applications include:

• Epitope tagging for protein detection via immunoblotting, immunofluorescence, and ELISA.
• Immunoprecipitation (IP) and co-immunoprecipitation (co-IP) for studying protein-protein interactions.
• Affinity purification of HA-tagged proteins from cell lysates using anti-HA magnetic beads or columns.
• Competitive elution of fusion proteins, preserving protein complexes for downstream analyses.
• Validation of ubiquitin pathway mechanisms, as in E3 ligase substrate identification (Dong et al., 2025, DOI).

Compared to other epitope tags (e.g., myc, FLAG), the HA tag is favored for its compact size, high specificity, and broad antibody compatibility. This article extends findings from earlier reviews (benchmarking overview), detailing molecular benchmarks and real-world troubleshooting not covered in previous guides.

Common Pitfalls or Misconceptions

• Endogenous HA-like sequences: The HA tag sequence is rare in mammalian proteins, but rare homologous motifs may exist; always validate antibody specificity in controls.
• Incomplete elution: Insufficient peptide concentration or incubation time may result in incomplete release of HA-tagged proteins during IP.
• Long-term solution storage: Storing peptide solutions at room temperature or 4°C for extended periods leads to degradation and reduced activity.
• Non-specific binding: Highly concentrated peptide may disrupt weak protein-protein interactions, leading to loss of complex partners.
• Denaturing conditions: The HA peptide is not effective for elution under harsh, denaturing conditions (e.g., SDS, urea); use milder buffers for best results.

Workflow Integration & Parameters

For optimal use of the Influenza Hemagglutinin (HA) Peptide (A6004), follow these integration guidelines:

• Dissolve peptide in DMSO, ethanol, or water at ≥10 mg/mL for stock solutions.
• Store lyophilized peptide desiccated at -20°C; reconstituted solutions should be freshly prepared or stored for no more than 1–2 weeks at -20°C.
• For immunoprecipitation elution, use 0.5–2 mg/mL HA peptide in neutral buffer (e.g., PBS, pH 7.2) for 15–30 minutes at 4°C with gentle mixing.
• Monitor elution efficiency by SDS-PAGE and immunoblotting.
• Consult peer-reviewed protocols and manufacturer documentation for workflow troubleshooting (see troubleshooting scenarios).

This article clarifies key experimental parameters and troubleshooting advice, updating and expanding on prior integration overviews (advanced strategies guide).

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide, as supplied by APExBIO, is a rigorously benchmarked, high-purity reagent central to modern molecular biology. Its robust performance in protein tagging and purification workflows is underpinned by extensive peer-reviewed validation and real-world application data. Ongoing advances in antibody engineering and proteomics will likely further expand the use cases and precision of the HA tag system. For up-to-date protocols and troubleshooting, consult the official product documentation and recent benchmarking reviews.